In plain language
In phantom work validated on 45 coronary angiograms by one cardiologist, over-apron chest dose closely tracked patient dose area product (R² 0.88-0.91), suggesting dose-area product (DAP) could help estimate cardiologist exposure. This is a dose estimation method, not a health outcome.
At a glance
- Type of study
- Original research, Phantom or simulation study
- Who was studied
- Interventional cardiologists, Phantom or simulation (no people), Patients
- Size
- n = 45 coronary angiography procedures
- Summary based on
- the abstract
What it found
Directly measured cardiologist over-apron exposure correlated linearly with DAP recorded by the X-ray system.
Key figures: R (2) = 0.88
Cardiologist exposure estimated from DAP using phantom-derived conversion factors agreed closely with measured exposure.
Key figures: R (2) = 0.91
Conversion factors were derived from phantom exposures at 77 predefined tube angulations as the quotient of over-apron exposure by DAP.
Key figures: 77 pre-defined directions
Authors conclude that cardiologist occupational exposure can be derived accurately from patient DAP data.
Limits to keep in mind
Conversion factors came from phantoms, and validation involved a single cardiologist over 45 procedures in patients of narrow weight range; only over-apron chest dose was assessed, and the country and shielding conditions are not reported in the abstract.
Related research summaries
- Patient And Staff Doses In Paediatric Interventional Cardiology Derived From Experimental Measurements With Phantoms (2015, Phantom or simulation study)
- Radiation exposure in interventional cardiology: Implications for patients and healthcare workers (2026, Dosimetry measurement study)
- Two Central Nervous System Tumors in One Catheter Lab: Time to Rethink Radiation Protection (2026, Retrospective cohort study)
- Investigation of radiation doses to the eyes of patients and medical staff during a videofluoroscopic swallowing study: a phantom study (2025, Phantom or simulation study)
- Reduced radiation exposure in the cardiac catheterization laboratory with a novel vertical radiation shield (2019, Prospective cohort study)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.